Recent Updates
Recently added Catalysts
SPRO Positive Sentiment Score: 60/100

Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

Tuesday, May 5, 2026 1 min read
Key Takeaway: Spero Therapeutics has announced it will report its first quarter 2026 financial results and provide a business update on May 13, 2026. The report will be released after market close, and the company has stated it will not hold a conference call. This reflects Spero's commitment to keeping stakeholders informed.

Market Sentiment Analysis

POSITIVE FACTORS

  • Spero Therapeutics is focused on developing treatments for rare diseases.
  • The company is actively reporting its financial results and business updates.
  • The upcoming report indicates transparency and engagement with investors.

Full Press Release Details

CAMBRIDGE, Mass., May 05, 2026 (GLOBE NEWSWIRE) --Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need, today announced that it will report its financial results for the first quarter ended March 31, 2026, and provide a business update on Wednesday, May 13, 2026, after market close. The Company does not intend to host a conference call.
About Spero TherapeuticsSpero Therapeutics, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need. For more information, visitwww.sperotherapeutics.com.

Investor Relations Contact:Shai Biran, PhDSpero TherapeuticsIR@Sperotherapeutics.com

Media Inquiries:media@sperotherapeutics.com

Frequently Asked Questions

When will Spero Therapeutics report its Q1 2026 results?

Spero Therapeutics will report its Q1 2026 results on May 13, 2026.

Will there be a conference call for the financial results?

No, Spero Therapeutics does not intend to host a conference call.

What is the focus of Spero Therapeutics?

Spero Therapeutics focuses on developing treatments for rare diseases.

Tags: SPRO Viatris Investor Conferences Healthcare Spero Therapeutics financial results Q1 2026 biopharmaceutical rare diseases
Last updated: May 5, 2026